{"title":"Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO<sub>2</sub>/FiO<sub>2</sub> Ratio a Predictor of Success.","authors":"Onkar K Jha, Sunny Kumar, Saurabh Mehra, Mrinal Sircar, Rajesh Gupta","doi":"10.5005/jp-journals-10071-23992","DOIUrl":null,"url":null,"abstract":"<p><p>In acute respiratory failure due to severe coronavirus disease 2019 (COVID-19) pneumonia, mechanical ventilation remains challenging and may result in high mortality. The use of noninvasive ventilation (NIV) may delay required invasive ventilation, increase adverse outcomes, and have a potential aerosol risk to caregivers. Data of 30 patients were collected from patient files and analyzed. Twenty-one (70%) patients were weaned successfully after helmet-NIV support (NIV success group), and invasive mechanical ventilation was required in 9 (30%) patients (NIV failure group) of which 8 (26.7%) patients died. In NIV success vs failure patients, the mean baseline PaO<sub>2</sub>/FiO<sub>2</sub> ratio (PFR) (147.2 ± 57.9 vs 156.8 ± 59.0 mm Hg; <i>p</i> = 0.683) and PFR before initiation of helmet (132.3 ± 46.9 vs 121.6 ± 32.7 mm Hg; <i>p</i> = 0.541) were comparable. The NIV success group demonstrated a progressive improvement in PFR in comparison with the failure group at 2 hours (158.8 ± 56.1 vs 118.7 ± 40.7 mm Hg; <i>p</i> = 0.063) and 24 hours (PFR-24) (204.4 ± 94.3 vs 121.3 ± 32.6; <i>p</i> = 0.016). As predictor variables, PFR-24 and change (delta) in PFR at 24 hours from baseline or helmet initiation (dPFR-24) were significantly associated with NIV success in univariate analysis but similar significance could not be reflected in multivariate analysis perhaps due to a small sample size of the study. The PFR-24 cutoff of 161 mm Hg and dPFR-24 cutoff of -1.44 mm Hg discriminate NIV success and failure groups with the area under curve (confidence interval) of 0.78 (0.62-0.95); <i>p</i> = 0.015 and 0.74 (0.55-0.93); <i>p</i> = 0.039, respectively. Helmet interface NIV may be a safe and effective tool for the management of patients with severe COVID-19 pneumonia with acute respiratory failure. More studies are needed to further evaluate the role of helmet NIV especially in patients with initial PFR <150 mm Hg to define PFR/dPFR cutoff at the earliest time point for prediction of helmet-NIV success. <b>How to cite this article</b> Jha OK, Kumar S, Mehra S, Sircar M, Gupta R<i>.</i> Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO<sub>2</sub>/FiO<sub>2</sub> Ratio a Predictor of Success. Indian J Crit Care Med 2021;25(10):1137-1146.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1137-1146"},"PeriodicalIF":1.5000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/14/35/ijccm-25-1137.PMC8645804.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-23992","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
In acute respiratory failure due to severe coronavirus disease 2019 (COVID-19) pneumonia, mechanical ventilation remains challenging and may result in high mortality. The use of noninvasive ventilation (NIV) may delay required invasive ventilation, increase adverse outcomes, and have a potential aerosol risk to caregivers. Data of 30 patients were collected from patient files and analyzed. Twenty-one (70%) patients were weaned successfully after helmet-NIV support (NIV success group), and invasive mechanical ventilation was required in 9 (30%) patients (NIV failure group) of which 8 (26.7%) patients died. In NIV success vs failure patients, the mean baseline PaO2/FiO2 ratio (PFR) (147.2 ± 57.9 vs 156.8 ± 59.0 mm Hg; p = 0.683) and PFR before initiation of helmet (132.3 ± 46.9 vs 121.6 ± 32.7 mm Hg; p = 0.541) were comparable. The NIV success group demonstrated a progressive improvement in PFR in comparison with the failure group at 2 hours (158.8 ± 56.1 vs 118.7 ± 40.7 mm Hg; p = 0.063) and 24 hours (PFR-24) (204.4 ± 94.3 vs 121.3 ± 32.6; p = 0.016). As predictor variables, PFR-24 and change (delta) in PFR at 24 hours from baseline or helmet initiation (dPFR-24) were significantly associated with NIV success in univariate analysis but similar significance could not be reflected in multivariate analysis perhaps due to a small sample size of the study. The PFR-24 cutoff of 161 mm Hg and dPFR-24 cutoff of -1.44 mm Hg discriminate NIV success and failure groups with the area under curve (confidence interval) of 0.78 (0.62-0.95); p = 0.015 and 0.74 (0.55-0.93); p = 0.039, respectively. Helmet interface NIV may be a safe and effective tool for the management of patients with severe COVID-19 pneumonia with acute respiratory failure. More studies are needed to further evaluate the role of helmet NIV especially in patients with initial PFR <150 mm Hg to define PFR/dPFR cutoff at the earliest time point for prediction of helmet-NIV success. How to cite this article Jha OK, Kumar S, Mehra S, Sircar M, Gupta R. Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO2/FiO2 Ratio a Predictor of Success. Indian J Crit Care Med 2021;25(10):1137-1146.
在2019年严重冠状病毒病(COVID-19)肺炎引起的急性呼吸衰竭中,机械通气仍然具有挑战性,并可能导致高死亡率。使用无创通气(NIV)可能会延迟所需的有创通气,增加不良后果,并对护理人员有潜在的气溶胶风险。从患者档案中收集30例患者资料进行分析。21例(70%)患者在头盔-NIV支持下成功脱机(NIV成功组),9例(30%)患者需要有创机械通气(NIV失败组),其中8例(26.7%)患者死亡。在NIV成功与失败的患者中,平均基线PaO2/FiO2比率(PFR)(147.2±57.9 vs 156.8±59.0 mm Hg);p = 0.683)和佩戴头盔前的PFR(132.3±46.9 vs 121.6±32.7 mm Hg;P = 0.541)具有可比性。与失败组相比,NIV成功组在2小时(158.8±56.1 vs 118.7±40.7 mm Hg)时PFR渐进式改善;p = 0.063)和24小时(PFR-24)(204.4±94.3 vs 121.3±32.6;P = 0.016)。作为预测变量,在单变量分析中,PFR-24和距基线24小时的PFR变化(δ)或头盔启动(dPFR-24)与NIV的成功显著相关,但由于研究样本量小,在多变量分析中无法反映出类似的意义。PFR-24截断值为161 mm Hg, dPFR-24截断值为-1.44 mm Hg,曲线下面积(置信区间)为0.78(0.62-0.95),区分NIV成功组和失败组;P = 0.015和0.74 (0.55 ~ 0.93);P = 0.039。头盔接口NIV可能是一种安全有效的工具,用于治疗COVID-19重症肺炎合并急性呼吸衰竭。Jha OK, Kumar S, Mehra S, Sircar M, Gupta R.头盔NIV在COVID-19急性低氧性呼吸衰竭中的作用:PaO2/FiO2比率的变化是成功的预测因子。中华检验医学杂志;2011;25(10):1137-1146。